Author

A. Hartmann

h-index 31 View on Semantic Scholar

We have 3 of 170 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Review Open access Oct 2026

The Prognostic Value of Lymphovascular Invasion in Combination with Nodal Stage on Disease-specific Survival in Patients with Bladder Cancer Following Upfront Radical Cystectomy.

The prognostic value of lymphovascular invasion (LVI) after radical cystectomy (RC) remains debated, particularly in relation to pathological tumor stage (pT) and pathological nodal status (pN). We analyzed the strongest prognostic factors for disease-specific survival (DSS) in a multicenter study with local pathology...

E. V. van Gennep, F. Claps, G. KleinJan et al. · European Urology Focus · 0 citations

Jul 2026

The role of the transcription factor Blimp-1 in T cells in anti-PD1 immunotherapy in non-small cell lung cancer 2258857

The data indicate that the tumor microenvironment induces Blimp-1 in immunosuppressive Treg and CD8+ T effector cells, thereby limiting the therapeutic efficacy of anti-tumor immune responses.

S. Finotto, M. Chiriac, Susanne Krammer et al. · Journal of Immunology · 0 citations

Meta-analysis Open access Aug 2026

Multi-population GWAS meta-analysis identifies bladder cancer susceptibility loci and highlights genetic regulation of smoking-related risk

A multi-population meta-analysis of genome-wide association studies, including 32,470 individuals with and 1,753,462 without bladder cancer, identifies 70 independent risk loci, of which 43 are novel, and uses experimental approaches to uncover how inherited variation influences this risk in the context of smoking.

L. Prokunina-Olsson, O. Flórez-Vargas, Michael G. Levin et al. · Nature Communications · 0 citations